Efferon vs Turn Therapeutics
Efferon vs Turn Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Efferon is on 45/100 and Turn Therapeutics on 38/100.
Where each one leads
Efferon
- our overall score: 45/100 against 38/100
- agent readiness: 52/100 against 21/100
- domain rating: 30/100 against 27/100
Turn Therapeutics
- funding raised: $25.0M against $17.5M
At a glance
| Measure | Efferon | Turn Therapeutics |
|---|---|---|
| What it is | Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock. | A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases. |
| Category | Biotechnology, Medical Devices, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2019 |
| Headquarters | Tel Aviv, Israel | Los Angeles, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Efferon | Turn Therapeutics |
|---|---|---|
| Total funding | $17.5M | $25.0M |
| Latest round | Seed | Loan Facility |
| Valuation | Not published | $101M |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Efferon | Turn Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 38/100 |
| Traction | 36/100 | 37/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 15/100 | 13/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (52/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 27/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Efferon | Turn Therapeutics |
|---|---|---|
| Hosting | Vercel | Not detected |
| CDN | Vercel | Cloudflare |
| CMS | Ghost | WordPress |
| Frameworks | Next.js | Jquery |
| Analytics | Not detected | Google Analytics 4, Hotjar, Facebook Pixel |
Efferon vs Turn Therapeutics: common questions
Which is better, Efferon or Turn Therapeutics?
On our 0-100 score Efferon rates higher (45/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Efferon and Turn Therapeutics compare on the numbers?
Efferon leads on our overall score (45/100 against 38/100), agent readiness (52/100 against 21/100), domain rating (30/100 against 27/100). Turn Therapeutics leads on funding raised ($25.0M against $17.5M).
Read the full Efferon review and pricing or the Turn Therapeutics review and pricing. You can also browse other Efferon alternatives we track.